Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Health-related quality of life in adolescents with or at risk for type 2 diabetes mellitus.
Cohort Effect
Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer.
Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors.
Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. JNCI Cancer Spectr. 2025 Jan 28.
View in:
PubMed
authors with profiles
Lawrence H. Kushi, ScD
Mai Nhu Nguyen-Huynh, MD, MAS
Marilyn L. Kwan, PhD